1 – 10 of 37
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Development, Validation, and Clinical Utility of a Six-gene Signature to Predict Aggressive Prostate Cancer
(
- Contribution to journal › Article
- 2022
-
Mark
Pre-clinical and clinical studies on the role of RBM3 in muscle-invasive bladder cancer : longitudinal expression, transcriptome-level effects and modulation of chemosensitivity
(
- Contribution to journal › Article
-
Mark
PRR11 unveiled as a top candidate biomarker within the RBM3-regulated transcriptome in pancreatic cancer
(
- Contribution to journal › Article
-
Mark
Analytical Validation of a Novel 6-Gene Signature for Prediction of Distant Recurrence in Estrogen Receptor-Positive, HER2-Negative, Early-Stage Breast Cancer
(
- Contribution to journal › Article
- 2020
-
Mark
A Functional Genomic Screen Identifies the Deubiquitinase USP11 as a Novel Transcriptional Regulator of ERα in Breast Cancer
(
- Contribution to journal › Article
- 2019
-
Mark
BET Inhibition as a Rational Therapeutic Strategy for Invasive Lobular Breast Cancer
2019) In Clinical cancer research : an official journal of the American Association for Cancer Research 25(23). p.7139-7150(
- Contribution to journal › Article
- 2018
-
Mark
A translational effort to identify prognostic and predictive biomarkers in pancreatic cancer among RBM3-regulated genes
(
- Contribution to conference › Poster
- 2017
-
Mark
Therapeutic rationale to target highly expressed CDK7 conferring poor outcomes in triple-negative breast cancer
(
- Contribution to journal › Article
-
Mark
Comprehensive DNA methylation study identifies novel progression-related and prognostic markers for cutaneous melanoma
(
- Contribution to journal › Article
- 2016
-
Mark
Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer.
(
- Contribution to journal › Article